LONDON (Alliance News) - Eco Animal Health Group PLC said Tuesday that it had received marketing authorisation for Aivlosin 42.5 milligram per gram premix, its treatment for respiratory disease in swine, in Korea. Authorisation was granted by the Animal and Plant Quarantine Agency in Korea.
Read moreLONDON (Alliance News) - Eco Animal Health Group PLC said Monday that it had been granted marketing authorisation by the Veterinary Drugs Director of Health Canada for its in-feed pig medication Aivlosin 17% premix. The Aivlosin 17% premix will be marketed for the treatment of porcine proli
Read moreLONDON (Alliance News) - ECO Animal Health Group PLC Monday said it has received a marketing authorization from the European Medicines Agency for the use of its Aivlosin 625 milogram per gram water soluble granules in turkeys. The authorization allows for the medication of drinking water wi
Read moreAIM-listed veterinary drug specialist ECO Animal Health enjoyed a strong first six months of the year, traditionally its weaker period. A robust drug pipeline and a strong start to the second half leaves company management optimistic about full year results. For the half-year to September 30th e
Read moreGas metering provider Energy Assets has secured a new bank funding facility and refinanced a portion of its existing debts. The FTSE Fledgling group has arranged a new £25m funding facility with Bank of Scotland with drawdowns at an interest rate of 2.95% above the London interbank rate (LIBOR) wh
Read more- Asia Pacific director sells 74,176 shares - Awarded as consideration for purchase of minority interests The Managing Director of SThree's Asia Pacific arm, Justin Hughes, this week sold off £264,808-worth of shares in the staffing business, which specialises in the IT sector. Hughes disposed
Read more